Impact of Empiric Linezolid for Necrotizing Soft Tissue Infections on Duration of Methicillin-Resistant Staphylococcus aureus-Active Therapy Empiric Linezolid Use for Necrotizing Soft Tissue Infections.
Sign Up to like & getrecommendations! Published in 2022 at "Surgical infections"
DOI: 10.1089/sur.2021.329
Abstract: Background: Necrotizing soft tissue infections (NSTIs) require prompt surgical debridement and antimicrobial therapy. Indicated antimicrobial therapy involves broad-spectrum coverage against common pathogens and toxin inhibition. Linezolid provides both methicillin-resistant Staphylococcus aureus (MRSA) coverage and toxin… read more here.
Keywords: necrotizing soft; therapy; empiric linezolid; tissue infections ... See more keywords